title: Low turnover bone disease in Egyptian children with acute leukemia.
abstract: The aim of this work was to study bone turnover markers, calcium homeostasis and bone mineral density (BMD) in children with acute leukemia at diagnosis, after induction chemotherapy, and during maintenance therapy to delineate abnormalities present. After evaluation of L2-L4 BMD using dual-energy X-ray absorptiometry in patients with acute myeloid and lymphoid leukemia at presentation and after treatment, the results were compared to 352 healthy age- and sex-matched Egyptian controls. Calcium homeostasis parameters and bone turnover biochemical markers (serum osteocalcin and urinary deoxypyridinoline) were also assayed and the results were compared to 12 healthy age- and sex-matched controls. Osteopenia was observed at diagnosis and during treatment in patients with acute leukemia. At diagnosis osteopenia was observed in 27 patients (62.8%): 10 (23.3%) had non severe osteopenia and 17 (39.5%) had severe osteopenia. This low BMD persisted in those who were followed up. Parathyroid hormone (PTH) (pg/ml) levels demonstrated non significant differences between children with acute leukemia at different stages of therapy and controls, while, 25 (OH) D3 (ng/ml) was significantly lower in acute leukemia patients at different stages of therapy compared to controls (p<0.001). Osteocalcin (ng/ml) is significantly lower in patients at different stages of the disease compared to controls (p<0.001) but there was no significant difference between patients at different stages of therapy. Deoxy-pyridoline cross links showed non-significant difference between the different types of acute leukemia and with controls. Osteopenia is a significant problem in children with acute leukemia at presentation and after chemotherapy. Osteopenia in acute leukemia appears to be of the low turnover type (decreased osteoblastic activity and decreased bone mineralization).
authors.affiliation: Endocrinology Unit, Pediatric Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
authors.forename: Magdy A
authors.initials: MA
authors.lastname: El-Ziny
authors.forename: Youssef A
authors.initials: YA
authors.lastname: Al-Tonbary
authors.forename: Osama S
authors.initials: OS
authors.lastname: Salama
authors.forename: Ashraf A
authors.initials: AA
authors.lastname: Bakr
authors.forename: Hala
authors.initials: H
authors.lastname: Al-Marsafawy
authors.forename: Ashraf A
authors.initials: AA
authors.lastname: Elsharkawy
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000097:blood* / Q000175:diagnosis / Q000209:etiology; D016723:Bone Remodeling; D002648:Child; D002675:Child, Preschool; D002762:Cholecalciferol / Q000097:blood; D004534:Egypt; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000097:blood* / Q000150:complications / Q000628:therapy; D008297:Male; D010006:Osteoblasts / Q000378:metabolism; D015675:Osteocalcin / Q000097:blood; D010281:Parathyroid Hormone / Q000097:blood
chemical_list: D010281:Parathyroid Hormone; D015675:Osteocalcin; D002762:Cholecalciferol